Product Information
- Ubrelvy
- Spiro[6H-cyclopenta[b]pyridine-6,3′-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide, 1′,2′,5,7-tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2′-oxo-, (3′S)-
- (3′S)-1′,2′,5,7-Tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2′-oxospiro[6H-cyclopenta[b]pyridine-6,3′-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide
- MK 1602
Ubrogepant is a small-molecule drug that is used to treat migraine. It inhibits the activity of a receptor called CGRP, which is associated with the development of migraine headaches. Ubrogepant has been shown to be effective in treating chronic cough and has also been found to be safe for long-term use. The drug does not have significant toxicity or major side effects. Ubrogepant may increase the risk of bleeding and gastrointestinal disorders when used with nonsteroidal anti-inflammatory drugs (NSAIDs).
Chemical properties
Technical inquiry about: 3D-FU165699 Ubrogepant
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
